First Wave to merge with Im­muno­genX; Cali­way rais­es $100M; New deals for Re­play’s Sye­na

First Wave Bio­Phar­ma’s merg­er plans: The Flori­da biotech said it plans to merge with Im­muno­genX, an­oth­er gas­troin­testi­nal dis­eases com­pa­ny that is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.